Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Total Knee Arthroplasty

NCT00132392 is registered in ClinicalTrials.gov with AlgoRx Pharmaceuticals as lead sponsor.

NCT NCT00132392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Total Knee Arthroplasty
Lead sponsor
AlgoRx Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
December 31, 2005
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, knee, knee injuries